Hydrogen Gas Shows Promise for Brain Protection During Surgery
- Authors
- Zhen Wang, Guolin Wang, Keliang Xie
- Journal
- Current Opinion in Anaethesiology
- Year
- 2020
- DOI
- 10.1097/ACO.0000000000000915
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Perioperative Neurological Complications
- Body System
- Nervous System
TL;DR
Scientists found that hydrogen gas might protect brains during surgery by fighting inflammation and damage, but we need more big studies to prove it actually works in real patients before doctors can start using it.
Key Finding
Molecular hydrogen shows promise for protecting nerve tissue through multiple mechanisms (reducing inflammation, preventing cell death, and protecting cellular energy centers), but clinical use remains limited because large-scale human trials are lacking.
Summary
This review examined research on molecular hydrogen—a simple gas—as a potential treatment to protect the brain and nervous system during and after surgery. Studies show that hydrogen may work by reducing harmful inflammation, preventing cell damage, and protecting energy-producing structures inside cells. However, most evidence comes from basic laboratory research, and there haven't been enough large, well-designed human studies to confirm whether hydrogen actually helps patients in real clinical settings.
Practical Takeaway
While early research suggests hydrogen may have neuroprotective properties, this is a review of existing studies rather than new clinical evidence. The authors emphasize that much more rigorous human research is needed before hydrogen can be recommended for perioperative neuroprotection. Anyone considering hydrogen water should be aware that evidence in surgical or neurological settings remains preliminary.
Abstract
Purpose of review: The current systematic review summarizes recent, basic clinical achievements regarding the neuroprotective effects of molecular hydrogen in distinct central nervous system conditions. Recent findings: Perioperative neuroprotection remains a major topic of clinical anesthesia. Various gaseous molecules have previously been explored as a feasible therapeutic option in neurological disorders. Among them, molecular hydrogen, which has emerged as a novel and potential therapy for perioperative neuroprotection, has received much attention. Summary: Fundamental and clinical evidence supports the antioxidant, antiinflammation, antiapoptosis and mitochondrial protective effects of hydrogen in the pathophysiology of nervous system diseases. The clinically preventive and therapeutic effects of hydrogen on different neural diseases, however, remain uncertain, and the lack of support by large randomized controlled trials has delayed its clinical application.